← Back to home

Document doj-ogr-00026117

AI Analysis

Summary: This medical record documents a medical examination of Jeffrey Epstein on July 14, 2019, noting his medical conditions, including constipation, hyperlipidemia, and low back pain, and detailing new medication orders and laboratory requests.
Significance: This document provides insight into Jeffrey Epstein's medical condition and treatment while in custody, potentially relevant to investigations or lawsuits related to his health and well-being.
Key Topics: Medical examination Medication orders Laboratory requests
Key People:
  • Jeffrey Edward Epstein - Inmate being examined
Document Type
Medical Record
Date
July 14, 2019
Pages
1
Folder
IMAGES010

Full Text

Page 2441 Inmate Name: EPSTEIN, JEFFREY EDWARD Sex: M Race: WHITE Reg #: 76318-054 Date of Birth: 01/20/1953 Encounter Date: 07/14/2019 17:36 Provider: [redacted] MD Facility: NYM Unit: Z05 Exam: Eyes General Yes: PERRLA, Extraocular Movements Intact Pulmonary Auscultation Yes: Clear to Auscultation Cardiovascular Auscultation Yes: Regular Rate and Rhythm (RRR), Normal S1 and S2 No: M/R/G Abdomen Auscultation Yes: Normo-Active Bowel Sounds Palpation Yes: Within Normal Limits Musculoskeletal Tibia / Fibula No: Edema Back Yes: Tenderness Neurologic Cranial Nerves (CN) Yes: Within Normal Limits Motor System-General Yes: Normal Exam ASSESSMENT: Constipation, unspecified, K5900 - Current Hyperlipidemia, unspecified, E785 - Current Low back pain, M545 - Current Neuralgia and neuritis, unspecified, M792 - Current Sleep apnea, G4730 - Current PLAN: New Medication Orders: Rx# Medication Order Date Prescriber Order Omega 3 (Vascepa) 1 GM Capsule 07/14/2019 17:36 TAKE 2 CAPS Orally - Two Times a Day x 180 day(s) - TAKE WITH FOOD. Indication: Hyperlipidemia, unspecified New Laboratory Requests: Details Frequency Due Date Priority Lab Tests-H-Hemoglobin A1C One Time 10/10/2019 00:00 Routine Lab Tests-L-Lipid Profile Additional Information: Generated 07/14/2019 18:11 by [redacted] MD Bureau of Prisons - NYM Page 2 of 3 DOJ-OGR-00026117